There are 133 resources available
Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer
Presenter: Anthony B. El-Khoueiry, United States
Session: Session I: Opening Session
Resources:
Slides
First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results
Presenter: Kei Muro, Japan
Session: Session I: Opening Session
Resources:
Slides
Discussant: LBA 0-9, LBA 0-10
Presenter: Ryan Corcoran, United States
Session: Session I: Opening Session
Resources:
Slides
Hereditary Predisposition to Pancreatic Cancer: Whom and How To Screen and What to Look For?
Presenter: Judith Balmaña, Spain
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Management of Pre-Malignant Pancreatic Lesions
Presenter: Pascal Hammel, France
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Clinical and molecular features of patients with KRAS wild-type pancreatic adenocarcinoma
Presenter: Imen Ben-Ammar, France
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Debate: Molecular Changes in Pancreatic Ductal Adenocarcinoma: NGS in All Patients With PDAC - PRO
Presenter: Thomas Seufferlein, Germany
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Debate: Molecular Changes in Pancreatic Ductal Adenocarcinoma: NGS in All Patients With PDAC - CON
Presenter: Jordan Berlin, United States
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Comparison of resected vs. non-resected patients with unresectable locally advanced pancreatic cancer (LAPC) receiving P-32 microparticles with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy in the PanCO study
Presenter: Paul Ross, United Kingdom
Session: Session II: Cancer of the Pancreas
Resources:
Slides
Cases With Panel Discussion: Resectable, Borderline Resectable, and Unresectable Pancreatic Cancer
Presenter: Eric Van Cutsem, Belgium; Margaret Tempero, United States; Oliver Strobel, Austria; Karin Haustermans, Belgium; Gerald Prager, Austria; Maria Antonietta Bali, Belgium
Session: Session II: Cancer of the Pancreas
Resources:
Slides